Welcome to our dedicated page for Phreesia SEC filings (Ticker: PHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Phreesia filings document the company’s operating results, material agreements, capital structure and governance as a public healthcare technology company. Recent Form 8-K disclosures include quarterly financial results, stakeholder letters and earnings-call materials, along with material definitive agreements connected to credit facilities, acquisition financing and receivables arrangements.
The filing record also documents the completed AccessOne acquisition, the use and refinancing of related debt, and subsidiary arrangements involving AccessOne Funding and AccessOne MedCard. Governance disclosures include board composition changes, director compensation matters and shareholder-voting subjects, while capital-structure disclosures cover secured revolving credit, bridge-loan obligations and receivables purchase agreements.
Phreesia (PHR) disclosed a Form 4 for CFO Balaji Gandhi. On 10/17/2025, he disposed of 885 shares of common stock at a weighted average price of $22.3612 in non‑discretionary sell‑to‑cover transactions to satisfy tax withholding tied to the settlement of restricted stock units.
Following the sale, he beneficially owns 98,240 shares, held directly. The shares were sold across multiple trades at prices ranging from $22.195 to $22.66 per share.
Phreesia, Inc. (PHR) reported an insider transaction by its General Counsel & Secretary. On 10/17/2025, the officer sold 1,241 shares of common stock (code S) in non-discretionary transactions executed under the company’s mandatory sell-to-cover policy tied to RSU settlement.
The weighted average sale price was $22.3612 per share, with individual trades ranging from $22.195 to $22.66. Following these transactions, the officer directly beneficially owned 135,737 shares.
Phreesia (PHR) insider activity: CEO and director Chaim Indig reported a sale of 3,163 shares of common stock on 10/17/2025. The filing states these shares were disposed of in non-discretionary transactions under the company’s mandatory sell-to-cover policy to satisfy tax withholding tied to the settlement of restricted stock units.
The weighted average sale price was $22.3612 per share, with individual trades executed between $22.195 and $22.66. Following the transaction, Indig beneficially owned 1,252,608 shares directly. An additional 255,000 shares were listed as indirectly owned through a family trust, whose sole beneficiaries are members of his immediate family.
Phreesia (PHR) reported an insider transaction by its President, Network Solutions. On 10/17/2025, the reporting person sold 2,059 shares of common stock (code S) at a weighted average price of $22.3612. The filing states the sales were non‑discretionary under the company’s mandatory sell‑to‑cover policy to satisfy tax withholding tied to the settlement of restricted stock units.
Following the transaction, the insider beneficially owned 171,829 shares directly and 9,883 shares indirectly through a spouse.
Phreesia (PHR): Officer Evan Roberts reported a Form 4 transaction showing the sale of 1,888 shares of common stock on 10/17/2025 at a weighted average price of $22.3612. The filing states the shares were disposed of in non-discretionary transactions under the issuer’s mandatory sell-to-cover policy to satisfy tax withholding tied to the settlement of performance-based RSUs.
Following the transaction, Roberts beneficially owned 724,949 shares, held directly.
Phreesia, Inc. (PHR) reported a Form 4 showing an officer transaction tied to tax withholding. On 10/17/2025, the company’s SVP, Human Resources disposed of 639 shares of common stock in non-discretionary sales under the issuer’s mandatory sell-to-cover policy related to the settlement of restricted stock units. The weighted average price was $22.3612, with individual trades executed between $22.195 and $22.66 per share.
Following the transactions, the reporting person beneficially owned 111,840 shares, held directly. The filing notes the availability of detailed trade breakdowns upon request.
Phreesia (PHR): A selling securityholder filed a Form 144 to sell 885 shares of common stock, with an approximate sale date of 10/17/2025 on the NYSE and an aggregate market value of 19789.66.
The 885 shares were acquired via restricted stock vesting on 10/14/2025 as compensation from the issuer. Shares outstanding were 59914473.
Recent Form 144 activity by Balaji Gandhi shows sales of 886 shares on 07/17/2025 for 23820.82, 9583 shares on 08/25/2025 for 287550.07, and 4183 shares on 09/16/2025 for 97398.65.
Phreesia (PHR) received a Rule 144 notice from Chaim Indig covering a proposed sale of 3,163 common shares with an aggregate market value of $70,728.48, with an approximate sale date of 10/17/2025 on the NYSE through Fidelity Brokerage Services LLC.
The shares to be sold were acquired via restricted stock vesting on 10/14/2025 as compensation. Recent Form 144 disclosures list prior sales by the filer in the last three months, including 92,247 shares on 08/27/2025, 7,746 on 08/28/2025, 6,328 on 09/16/2025, and 3,171 on 07/17/2025. Shares outstanding were 59,914,473.
Phreesia (PHR): A security holder filed a Form 144 notice to sell 1,241 common shares, with an aggregate market value of $27,750.25, on or about October 17, 2025 on the NYSE through Fidelity Brokerage Services.
The shares were acquired on October 14, 2025 via restricted stock vesting from the issuer as compensation. Phreesia reported 59,914,473 shares outstanding. The same seller disclosed prior 3‑month sales: 1,245 shares for $33,472.82 (07/17/2025), 3,133 shares for $72,950.03 (09/16/2025), and 2,059 shares for $48,386.50 (09/17/2025).
PHR filed a Form 144 notice for a planned sale of 2,059 common shares, with an aggregate market value of $46,041.71. The filer lists Fidelity Brokerage Services LLC as broker, an approximate sale date of 10/17/2025, and the NYSE as the exchange. The shares were acquired on 10/14/2025 via restricted stock vesting from the issuer as compensation.
Shares outstanding were 59,914,473 at the time referenced in the form. The filing also lists recent sales over the past three months by the named sellers, including multiple transactions with stated share counts and gross proceeds. This notice reflects intended sales under Rule 144 and pertains to the selling securityholder’s shares; it does not involve the company raising capital.